• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,328.19 -516.33
( -0.66%)
Global Indices
Nasdaq
49,619.91 1.93
(0.00%)
Dow Jones
7,417.79 59.68
(0.81%)
Hang Seng
62,681.30 -152.54
(-0.24%)
Nikkei 225
10,228.01 -48.94
(-0.48%)
Forex
USD-INR
94.38 -0.30
(-0.31%)
EUR-INR
110.93 -0.26
(-0.23%)
GBP-INR
128.32 -0.39
(-0.30%)
JPY-INR
0.60 0.00
(-0.28%)

EQUITY - MARKET SCREENER

Eiko Lifesciences Ltd
Industry :  Chemicals
BSE Code
ISIN Demat
Book Value()
540204
INE666Q01016
42.7795752
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
23.23
71.99
EPS(TTM)
Face Value()
Div & Yield %
2.16
10
0
 

Aries Agro jumps on inaugurating relocated manufacturing unit in Uttar Pradesh
Mar 05,2026
In an exchange filing, the company said the new unit, located at Village Chaktaliya Moodh in Tehsil Purwa, was inaugurated on 5 March 2026. The facility replaces the company's earlier manufacturing unit in Lucknow.

Aries Agro said the relocation does not involve any additional capacity expansion. The company’s installed production capacity remains unchanged at 1,01,400 metric tonnes per annum, with current capacity utilisation at about 71.8%.

Commercial production from the relocated facility is expected to commence by the end of March 2026. The project involves an investment of approximately Rs 12 crore, which is being funded through internal accruals.

Aries Agro is engaged in the manufacturing of micronutrients and other customized nutritional products for plants and animals.

On a consolidated basis, Aries Agro's net profit rose 48.88% to Rs 17.24 crore while net sales rose 19.57% to Rs 200.94 crore in Q3 December 2025 over Q3 December 2024.